Literature DB >> 10900351

Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats.

N Tanuma1, T Shin, Y Matsumoto.   

Abstract

This study was undertaken to better understand the role of cytokines in the pathogenesis, especially in the mechanisms of relapse, of experimental autoimmune encephalomyelitis (EAE). For this purpose, we induced acute and chronic relapsing (CR) EAE in DA rats and determined several immunological parameters in rats at various stages of two types of EAE. Histopathological analysis revealed that there was no significant difference in the severity of inflammation in the spinal cord lesions between the two groups. However, demyelination was observed only in rats with CR EAE. Cytokine analysis by competitive PCR demonstrated that levels of TNF-alpha, IL-6 and IL-12 p40 mRNA in the spinal cord at the first attack of CR EAE were significantly higher than those at the peak stage of acute EAE. The mRNA expression of anti-inflammatory cytokines, IL-10 and TGF-beta1, was generally low in both acute EAE and the first attack of CR EAE and upregulated at later stages of CR EAE. These findings suggest that persistent high-level expression of pro-inflammatory cytokines is closely associated with demyelination and relapse of EAE. In contrast, anti-inflammatory cytokines play only a minor role in the relapse.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900351     DOI: 10.1016/s0165-5728(00)00309-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Evaluation of oxidative stress and inflammation in long term Brucella melitensis infection.

Authors:  Ismet M Melek; Suat Erdogan; Sefa Celik; Ozkan Aslantas; Taskin Duman
Journal:  Mol Cell Biochem       Date:  2006-06-30       Impact factor: 3.396

Review 2.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

Authors:  Cris S Constantinescu; Nasr Farooqi; Kate O'Brien; Bruno Gran
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 3.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

Review 4.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

5.  Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease.

Authors:  Mercedes Fernandez; Alessandro Giuliani; Stefania Pirondi; Giulia D'Intino; Luciana Giardino; Luigi Aloe; Rita Levi-Montalcini; Laura Calzà
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

6.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

7.  Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis.

Authors:  Dušan Radojević; Marina Bekić; Alisa Gruden-Movsesijan; Nataša Ilić; Miroslav Dinić; Aleksandar Bisenić; Nataša Golić; Dragana Vučević; Jelena Đokić; Sergej Tomić
Journal:  Gut Microbes       Date:  2022 Jan-Dec

8.  Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages.

Authors:  Taekyun Shin; Meejung Ahn; Yoh Matsumoto
Journal:  Anat Cell Biol       Date:  2012-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.